European S3-Guidelines on the systemic treatment of psoriasis vulgaris D Pathirana, AD
Ormerod, P Saiag, C Smith, PI Spuls, A Na Page 1 JEADV october 2009, volume 23 …

This is an executive summary of all consented recommendations of the European Psoriasis
Guidelines–Update 2015. The long version of this guideline is available online as …

This evidence‐and consensus‐based guideline on the treatment of psoriasis vulgaris was
developed following the EuroGuiDerm Guideline and Consensus Statement Development …

The article presents a report on the updates in the European S3-Guideline on systemic
treatment of psoriasis vulgaris in cooperation with the European Academy of Dermatology …

The authors of this work have adapted, remixed, transformed, translated or built upon the pre-
peer reviewed version of the following article:“EuroGuiDerm Guideline on the systemic …

Psoriasis is a highly prevalent disease with a major impact on quality of life; therefore,
appropriate patient management is mandatory. Given that many issues in psoriasis are …

Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence
of psoriasis in Western industrialized countries ranges from 1.5% to 2%. Patients afflicted …

Background There is a high level of heterogeneity regarding the practical use of
conventional systemic treatment in psoriasis. Objectives The aim of this study was to …

Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence
of psoriasis in Western industrialized countries ranges from 1.5 to 2%. Patients afflicted with …

Background and objectives A new, updated AEDV Psoriasis Group (GPs) consensus
document on the treatment of moderate to severe psoriasis was needed owing to the …